• 1
    Sedlis A, Robboy SJ. Diseases of the vagina. In: Kurman, ed. Blausteins’s Pathology of the Female Genital Tract. New York: Springer, 1987:98140.
  • 2
    Gruessner SEM, Omwandho COA, Dreyer T et al. Management of stage 1 cervical sarcoma botryoides in childhood and adolescence. Europ J Paed 2004;163:4526.
  • 3
    Hahlin M, Jaworski RC, Wain GV et al. Integrated multimodality therapy for embryonal rhabdomyosarcoma of the lower genital tract in postpubertal females. Gynecol Oncol 1998;70:1416.
  • 4
    Andrassy RJ. Advances in the surgical management of children. Am J Surg 2002;184:48491.
  • 5
    Andrassy RJ, Weiner ES, Raney RB, Hays DM, Arndt CAS, Lobe TE. Progress in the surgical management of rhabdomyosarcoma: a 25 year review from the Intergroup Rhabdomyosarcoma Study Group. J Paed Surg 1999;34:7315.
  • 6
    Fleming DI, Ectubanas E, Patterson R et al. The role of surgical resection when combined with chemotherapy and radiation in the management of pelvic rhabdomyosarcoma. Ann Surg 1984;199:50914.
  • 7
    Ashlock R, Johnstone PA. Treatment modalities of bladder/prostrate rhabdomyosarcoma review. Prostrate Cancer Prostatic Dis 2003;6:11220.
  • 8
    McDowell HP. Update on childhood rhabdomyosarcoma. Arch Dis Child 2003;88:3547.
  • 9
    Shiu MH, Turnbull AD, Nori D et al. Control of locally advanced extremity soft tissue sarcomas by function saving resection and brachytherapy. Cancer 1984;53:138592.
  • 10
    Nag S, Tippin D, Ruymann FB. Long term morbidity in children treated with fractionated high-dose-rate brachytherapy for soft tissue sarcomas. J Pediatr Hematol Oncol 2003;25:44852.
  • 11
    Arndt CAS, Donaldson SS, Anderson JR et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer 2001;91:245468.